Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Implementation of surfactant treatment during continuous positive airway pressure

Abstract

Objective:

To study the effects of implementing a method for surfactant administration by transient intubation, INSURE (i.e. INtubation SURfactant Extubation) during nasal continuous positive airway pressure (nCPAP) for moderately preterm infants with respiratory distress syndrome (RDS).

Study design:

A descriptive, retrospective, bi-center study in Stockholm, Sweden, comparing mechanical ventilation (MV) rates, surfactant use, treatment response and outcome of all inborn infants with gestational age 27 to 34 weeks and RDS, (n=420), during the 5-year periods before and after the introduction of the INSURE-strategy at one of the centers (Karolinska Huddinge) in 1998. The other center (Karolinska Solna) continued conventional surfactant therapy in conjunction with MV throughout the study.

Results:

Implementation of INSURE at Karolinska Huddinge reduced the number of infants requiring MV by 50% (P<0.01), resulted in earlier surfactant administration and increased overall surfactant use. INSURE-treatment improved oxygenation and the treatment response was sustained over time with only 17% of the infants requiring >1 dose of surfactant. At Karolinska Solna, the MV rates were unaltered between the first and second 5-year period.

Conclusion:

Implementing a strategy of surfactant administration by transient intubation during nCPAP reduces the need for MV without adverse effects on outcome and may be an option to more effectively treat RDS, particularly in a care setting where transfer is necessary to provide MV.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Berggren E, Liljedahl M, Winbladh B, Andreasson B, Curstedt T, Robertson B et al. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr 2000; 89: 460–464.

    Article  CAS  PubMed  Google Scholar 

  2. Arroe M, Pedersen-Bjergaard L, Albertsen P, Bode S, Greisen G, Jonsbo F . Inhalation of aerosolized surfactant (Exosurf) to neonates treated with continuous positive airway pressure. Prenat Neonat Med 1998; 3: 346–352.

    Google Scholar 

  3. Dreyfuss D, Saumon G . Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998; 157: 294–323.

    Article  CAS  PubMed  Google Scholar 

  4. Parker JC, Hernandez LA, Peevy KJ . Mechanisms of ventilator-induced lung injury. Crit Care Med 1993; 21: 131–143.

    Article  CAS  PubMed  Google Scholar 

  5. Bohlin K, Bouhafs RK, Jarstrand C, Curstedt T, Blennow M, Robertson B . Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits. Pediatr Res 2005; 57: 624–630.

    Article  CAS  PubMed  Google Scholar 

  6. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000; 105: 1194–1201.

    Article  CAS  PubMed  Google Scholar 

  7. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987; 79: 26–30.

    CAS  PubMed  Google Scholar 

  8. Victorin LH, Deverajan LV, Curstedt T, Robertson B . Surfactant replacement in spontaneously breathing babies with hyaline membrane disease – a pilot study. Biol Neonate 1990; 58: 121–126.

    Article  CAS  PubMed  Google Scholar 

  9. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994; 331: 1051–1055.

    Article  CAS  PubMed  Google Scholar 

  10. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999; 103: E24.

    Article  CAS  PubMed  Google Scholar 

  11. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli F . Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants &lt;30 weeks gestation. Pediatrics 2004; 113: 560–563.

    Article  Google Scholar 

  12. Reininger A, Khalak R, Kendig J, Ryan R, Stevens T, Reubens L et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: A randomized controlled trial. J Perinatol 2005; 25: 703–708.

    Article  CAS  PubMed  Google Scholar 

  13. Kamper J, Wulff K, Larsen C, Lindequist S . Early treatment with nasal continuous positive airway pressure in very low-birth-weight infants. Acta Paediatr 1993; 82: 193–197.

    Article  CAS  PubMed  Google Scholar 

  14. Jonsson B, Katz-Salamon M, Faxelius G, Broberger U, Lagercrantz H . Neonatal care of very-low-birthweight infants in special-care units and neonatal intensive-care units in Stockholm. Early nasal continuous positive airway pressure versus mechanical ventilation: gains and losses. Acta Paediatr Suppl 1997; 419: 4–10.

    Article  CAS  PubMed  Google Scholar 

  15. Hjalmarson O . Epidemiology and classification of acute, neonatal respiratory disorders. A prospective study. Acta Paediatr Scand 1981; 70: 773–783.

    Article  CAS  PubMed  Google Scholar 

  16. Benveniste D, Berg O, Pedersen JE . A technique for delivery of continuous positive airway pressure to the neonate. J Pediatr 1976; 88: 1015–1019.

    Article  CAS  PubMed  Google Scholar 

  17. Shennan A, Dunn M, Ohlsson A, Lennox K, Hoskins E . Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527–532.

    CAS  PubMed  Google Scholar 

  18. Papile LA, Burstein J, Burstein R, Koffler H . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92: 529–534.

    Article  CAS  PubMed  Google Scholar 

  19. Gobel W, Richard G . Retinopathy of prematurity – current diagnosis and management. Eur J Pediatr 1993; 152: 286–290.

    Article  CAS  PubMed  Google Scholar 

  20. Yost CC, Soll RF . Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000; (2), CD001456.

  21. Kamper J . Early nasal continuous positive airway pressure and minimal handling in the treatment of very-low-birth-weight infants. Biol Neonate 1999; 76 (Suppl 1): 22–28.

    Article  CAS  PubMed  Google Scholar 

  22. Verder H, Ebbesen F, Linderholm B, Robertson B, Eschen C, Arroe M et al. Prediction of respiratory distress syndrome by the microbubble stability test on gastric aspirates in newborns of less than 32 weeks' gestation. Acta Paediatr 2003; 92: 728–733.

    Article  CAS  PubMed  Google Scholar 

  23. Björklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 1997; 42: 348–355.

    Article  PubMed  Google Scholar 

  24. Jobe AH, Kramer BW, Moss TJ, Newnham JP, Ikegami M . Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs. Pediatr Res 2002; 52: 387–392.

    Article  PubMed  Google Scholar 

  25. Speer CP, Robertson B, Curstedt T, Halliday HL, Compagnone D, Gefeller O et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 1992; 89: 13–20.

    CAS  PubMed  Google Scholar 

  26. Stevens TP, Blennow M, Soll RF . Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2004; (3), CD003063.

Download references

Acknowledgements

We thank the neonatal staff at Karolinska Huddinge and Solna for their support and skilled care of these infants. This work was supported by grants from the Swedish Society of Medicine and the Swedish Freemasons in Stockholm Foundation for Children's Welfare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Bohlin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bohlin, K., Gudmundsdottir, T., Katz-Salamon, M. et al. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol 27, 422–427 (2007). https://doi.org/10.1038/sj.jp.7211754

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211754

Keywords

This article is cited by

Search

Quick links